High-cost treatments: resources are not infinite

Main Article Content

Carlos E. García

Abstract

Commentary on a controversial topic such as the administration of high-cost drugs.

Downloads

##plugins.themes.bootstrap3.displayStats.noStats##
Published: 2024-06-28
Keywords:
high-cost drug, controversy, comment

Article Details

Section

Controversy

How to Cite

1.
García CE. High-cost treatments: resources are not infinite. Rev Hosp Ital B.Aires [Internet]. 2024 Jun. 28 [cited 2026 Jul. 31];44(3):e0000395. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/395

References

Augustovski F. Evaluaciones económicas en salud I: ¿son válidos los resultados de este estudio? Eviden Aten Primaria. 2002;5(4):123-126. https://doi.org/10.51987/evidencia.v5i4.5309.

Augustovski F. Evaluaciones económicas en salud II: ¿cuáles son los resultados? ¿Ayudarán en el cuidado de los pacientes? Eviden Aten Primaria. 2002;5(5):154-157. https://doi.org/10.51987/evidencia.v5i5.5295.

Mauskopf JA, Earnshaw S, Mullins CD. Budget impact analysis: review of the state of the art. Expert Rev Pharmacoecon Outcomes Res. 2005 Feb;5(1):65-79. https://doi.org/10.1586/14737167.5.1.65.

Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics. 2001;19(6):609-621. https://doi.org/10.2165/00019053-200119060-00001.

Most read articles by the same author(s)